Form 8-K - Current report:
SEC Accession No. 0000896264-24-000168
Filing Date
2024-05-07
Accepted
2024-05-07 16:01:50
Documents
13
Period of Report
2024-05-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K usna-20240506.htm   iXBRL 8-K 40405
  Complete submission text file 0000896264-24-000168.txt   163172

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20240506.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20240506_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20240506_pre.xml EX-101.PRE 12504
16 EXTRACTED XBRL INSTANCE DOCUMENT usna-20240506_htm.xml XML 2732
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 24921657
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)